Chairs I understand your cynicism as someone who invested heavily with cbio but there is no doubt in my mind Invion have something that the major pharmas want. My confidence in Invion 103 has certainly taken a hit, but Invion 102 has lived up to every expectation ( remember Retirewell due diligence prior to the merger Dr Israel ).
Invion is sitting on a novel ready to go phase 3 blockbuster drug in multi billion dollar markets of asthma, copd, smoking cessation and more than likely cystic fibrosis. Management can certainly be questioned on money concerns, lack of communication, trial delays..... but overall have delivered on our flagship Invion 102. I am invested heavily, don't know if I will ever get all my money back, but do know Invion 102 is worth a whole lot more than 8 million.
IVX Price at posting:
0.7¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)